| Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
|---|---|---|---|---|---|---|---|
| ENST00000566254 | CFDP1-206 | 342 | - | ENSP00000455564 | 50 (aa) | - | H3BQ17 |
| ENST00000570279 | CFDP1-210 | 349 | - | - | - (aa) | - | - |
| ENST00000564793 | CFDP1-204 | 457 | - | - | - (aa) | - | - |
| ENST00000570103 | CFDP1-209 | 663 | - | - | - (aa) | - | - |
| ENST00000283882 | CFDP1-201 | 1275 | XM_011522814 | ENSP00000283882 | 299 (aa) | XP_011521116 | Q9UEE9 |
| ENST00000562602 | CFDP1-202 | 699 | - | - | - (aa) | - | - |
| ENST00000564286 | CFDP1-203 | 775 | - | - | - (aa) | - | - |
| ENST00000569341 | CFDP1-208 | 454 | - | ENSP00000462862 | 19 (aa) | - | J3KT89 |
| ENST00000566901 | CFDP1-207 | 1167 | - | - | - (aa) | - | - |
| ENST00000565646 | CFDP1-205 | 608 | - | - | - (aa) | - | - |
| ENST00000612761 | CFDP1-211 | 395 | - | ENSP00000481200 | 17 (aa) | - | A0A087WXQ2 |
| ensgID | Trait | pValue | Pubmed ID |
|---|---|---|---|
| ENSG00000153774 | Platelet Function Tests | 2.8082300E-005 | - |
| ENSG00000153774 | Plaque, Atherosclerotic | 1.7310000E-005 | 21909108 |
| ENSG00000153774 | Plaque, Atherosclerotic | 3.9280000E-006 | 21909108 |
| ENSG00000153774 | Plaque, Atherosclerotic | 2.2040000E-005 | 21909108 |
| ENSG00000153774 | Plaque, Atherosclerotic | 5.4590000E-006 | 21909108 |
| ENSG00000153774 | Plaque, Atherosclerotic | 1.9440000E-006 | 21909108 |
| ENSG00000153774 | Lung Volume Measurements | 2E-11 | 21946350 |
| ENSG00000153774 | Respiratory Function Tests | 2E-11 | 21946350 |
| ENSG00000153774 | Lung Volume Measurements | 2E-8 | 23284291 |
| ENSG00000153774 | Pulmonary Disease, Chronic Obstructive | 1E-11 | 28166215 |
| ENSG00000153774 | Lung Volume Measurements | 4E-10 | 28166213 |
| ENSG00000153774 | Forced Expiratory Volume | 4E-6 | 28166213 |
| ENSG00000153774 | Migraine Disorders | 6E-8 | 27182965 |
| ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
|---|---|---|---|---|---|---|---|---|---|
| ENSG00000153774 | rs77505915 | 16 | 75408245 | T | Migraine | 27322543 | [1.03-1.06] | 1.05 | EFO_0003821 |
| ENSG00000153774 | rs2865531 | 16 | 75356418 | ? | Pulmonary function (smoking interaction) | 23284291 | EFO_0003892|EFO_0005671|EFO_0004713 | ||
| ENSG00000153774 | rs11640018 | 16 | 75294410 | G | Moyamoya disease | 29273593 | [NR] | 1.2345679 | Orphanet_2573 |
| ENSG00000153774 | rs12930452 | 16 | 75428157 | A | Coronary artery disease | 29212778 | [0.038-0.066] unit decrease | 0.052 | EFO_0000378 |
| ENSG00000153774 | rs4888378 | 16 | 75298143 | A | Coronary artery disease | 29212778 | [0.033-0.055] unit decrease | 0.0439 | EFO_0000378 |
| ENSG00000153774 | rs8046696 | 16 | 75408245 | T | Coronary artery disease | 29212778 | [0.037-0.059] unit decrease | 0.0479 | EFO_0000378 |
| ENSG00000153774 | rs17696696 | 16 | 75359454 | G | Aortic root size | 28394258 | [0.01-0.022] cm decrease | 0.016 | EFO_0005037 |
| ENSG00000153774 | rs3743609 | 16 | 75433123 | C | Lung function (FEV1) | 28166213 | [0.017-0.045] unit decrease | 0.031 | EFO_0004314 |
| ENSG00000153774 | rs3743609 | 16 | 75433123 | C | Lung function (FEV1/FVC) | 28166213 | [0.028-0.056] unit decrease | 0.042 | EFO_0004713 |
| ENSG00000153774 | rs2865531 | 16 | 75356418 | T | Pulmonary function | 21946350 | [0.021-0.041] unit increase | 0.031 | EFO_0003892|EFO_0004713 |
| ENSG00000153774 | rs200914569 | 16 | 75408247 | ? | Migraine | 27182965 | [1.03-1.06] | 1.0449321 | EFO_0003821 |
| ENSG00000153774 | rs11643209 | 16 | 75297146 | T | Systolic blood pressure | 28135244 | [0.24-0.44] unit decrease | 0.339 | EFO_0006335 |
| ENSG00000153774 | rs4888411 | 16 | 75409285 | ? | Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) | 29455858 | EFO_0006527|EFO_0006336 | ||
| ENSG00000153774 | rs4888411 | 16 | 75409285 | ? | Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) | 29455858 | EFO_0006527|EFO_0006335 | ||
| ENSG00000153774 | rs4888411 | 16 | 75409285 | ? | Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) | 29455858 | EFO_0006527|EFO_0006335 | ||
| ENSG00000153774 | rs4888411 | 16 | 75409285 | ? | Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) | 29455858 | EFO_0006527|EFO_0006335 | ||
| ENSG00000153774 | rs4888411 | 16 | 75409285 | ? | Systolic blood pressure x smoking status (ever vs never) interaction (2df test) | 29455858 | EFO_0006527|EFO_0006335 | ||
| ENSG00000153774 | rs4888411 | 16 | 75409285 | ? | Systolic blood pressure x smoking status (ever vs never) interaction (2df test) | 29455858 | EFO_0006527|EFO_0006335 | ||
| ENSG00000153774 | rs4888411 | 16 | 75409285 | ? | Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) | 29455858 | EFO_0006527|EFO_0006336 | ||
| ENSG00000153774 | rs113309773 | 16 | 75398789 | ? | Carotid plaque | 30510157 | [0.088-0.164] unit decrease | 0.1259 | EFO_0009783 |
| ENSG00000153774 | rs766522 | 16 | 75390212 | ? | Cardiovascular disease | 30595370 | EFO_0000319 | ||
| ENSG00000153774 | rs192422186 | 16 | 75394552 | ? | Aspartate aminotransferase levels in low alcohol consumption | 30589442 | [0.085-0.21] unit increase | 0.1473 | EFO_0004736|EFO_0007878 |
| ENSG00000153774 | rs12449170 | 16 | 75429114 | T | Pulse pressure | 30578418 | [0.18-0.28] mmHg increase | 0.2264 | EFO_0005763 |
| ENSG00000153774 | rs12449170 | 16 | 75429114 | T | Systolic blood pressure | 30578418 | [0.24-0.37] mmHg increase | 0.3022 | EFO_0006335 |
| ENSG00000153774 | rs11858992 | 16 | 75377547 | A | FEV1 | 30804560 | [0.018-0.027] unit increase | 0.0224 | EFO_0004314 |
| ENSG00000153774 | rs11858992 | 16 | 75377547 | A | Lung function (FEV1/FVC) | 30804560 | [0.033-0.043] unit increase | 0.038 | EFO_0004713 |
| ENSG00000153774 | rs11858992 | 16 | 75377547 | A | Peak expiratory flow | 30804560 | [0.025-0.035] unit increase | 0.0303 | |
| ENSG00000153774 | rs35261357 | 16 | 75410674 | C | Systolic blood pressure | 27841878 | unit decrease | 0.265 | EFO_0006335 |
| ENSG00000153774 | rs35261357 | 16 | 75410674 | C | Pulse pressure | 27841878 | unit decrease | 0.216 | EFO_0005763 |
| ENSG00000153774 | rs4888420 | 16 | 75429100 | ? | Lung function (FEV1/FVC) | 30595370 | EFO_0004713 | ||
| ENSG00000153774 | rs1549306 | 16 | 75381443 | ? | Chronic obstructive pulmonary disease or high blood pressure (pleiotropy) | 30940143 | EFO_0004325|EFO_0000341 | ||
| ENSG00000153774 | rs8046697 | 16 | 75408246 | ? | Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy) | 30940143 | EFO_0000341|EFO_0000378 |

| Ensembl ID | Gene Symbol | Coverage | Identiy | Ortholog | Gene Symbol | Coverage | Identiy | Species |
|---|---|---|---|---|---|---|---|---|
| ENSG00000153774 | CFDP1 | 100 | 81.271 | ENSMUSG00000031954 | Cfdp1 | 100 | 80.602 | Mus_musculus |
| Go ID | Go_term | PubmedID | Evidence | Category |
|---|---|---|---|---|
| GO:0000777 | condensed chromosome kinetochore | - | IEA | Component |
| GO:0003674 | molecular_function | - | ND | Function |
| GO:0005575 | cellular_component | - | ND | Component |
| GO:0007155 | cell adhesion | - | IEA | Process |
| GO:0007275 | multicellular organism development | - | IEA | Process |
| GO:0008150 | biological_process | - | ND | Process |
| GO:0008360 | regulation of cell shape | - | IEA | Process |
| GO:0042127 | regulation of cell proliferation | - | IEA | Process |
| GO:2000270 | negative regulation of fibroblast apoptotic process | - | IEA | Process |